QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
NASDAQ:LMDX

LumiraDx (LMDX) Stock Price, News & Analysis

$0.0098
0.00 (0.00%)
(As of 02/23/2024 ET)
Today's Range
$0.0086
$0.01
50-Day Range
$0.01
$0.09
52-Week Range
$0.02
$1.33
Volume
1.07 million shs
Average Volume
56.75 million shs
Market Capitalization
$3.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.45

LMDX stock logo

About LumiraDx Stock (NASDAQ:LMDX)

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.

LMDX Stock Price History

LMDX Stock News Headlines

LMDX.O
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Why Is LumiraDx (LMDX) Stock Down 13% Today?
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
LumiraDx Agrees To Sell Point-of-Care Tech Platform To Roche
LumiraDx Limited (LMDX)
LumiraDx Ltd LMDX
What Makes LumiraDx Limited (LMDX) a New Buy Stock
See More Headlines
Receive LMDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LumiraDx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/24/2023
Today
2/26/2024
Next Earnings (Estimated)
3/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMDX
Fax
N/A
Employees
1,210
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.45
High Stock Price Target
$2.70
Low Stock Price Target
$0.80
Potential Upside/Downside
+8,962.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-447,790,000.00
Net Margins
-268.45%
Pretax Margin
-264.58%

Debt

Sales & Book Value

Annual Sales
$126.52 million
Book Value
($0.33) per share

Miscellaneous

Free Float
205,749,000
Market Cap
$5.10 million
Optionable
Not Optionable
Beta
1.73
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Ms. Veronique Ameye EMBA (Age 46)
    Esq., M.B.A., CEO & General Counsel
  • Mr. Dorian LeBlanc CPA (Age 48)
    CFO & VP of Global Operations
  • Ms. Colleen McMillen
    Vice President of Communications
  • Andy Ward
    National Sales Director - UK
  • Mr. David Walton DMS (Age 69)
    Chief Commercial Officer
  • Giffin Daughtridge
    President of North America Commercial Operations & Global Molecular Solutions
  • Melissa Garcia
    VP & Corporate Counsel














LMDX Stock Analysis - Frequently Asked Questions

Should I buy or sell LumiraDx stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LumiraDx in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" LMDX shares.
View LMDX analyst ratings
or view top-rated stocks.

What is LumiraDx's stock price target for 2024?

2 brokerages have issued 12 month price objectives for LumiraDx's shares. Their LMDX share price targets range from $0.80 to $2.70. On average, they expect the company's share price to reach $1.45 in the next year. This suggests a possible upside of 14,695.9% from the stock's current price.
View analysts price targets for LMDX
or view top-rated stocks among Wall Street analysts.

How have LMDX shares performed in 2024?

LumiraDx's stock was trading at $0.0629 on January 1st, 2024. Since then, LMDX shares have decreased by 84.4% and is now trading at $0.0098.
View the best growth stocks for 2024 here
.

When is LumiraDx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our LMDX earnings forecast
.

How were LumiraDx's earnings last quarter?

LumiraDx Limited (NASDAQ:LMDX) posted its quarterly earnings results on Thursday, August, 24th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by $0.01. The company earned $21 million during the quarter, compared to analysts' expectations of $21.07 million. During the same quarter in the prior year, the firm earned ($0.58) earnings per share.

Who are LumiraDx's major shareholders?

LumiraDx's stock is owned by a variety of retail and institutional investors. Top institutional investors include Senvest Management LLC (2.53%).

How do I buy shares of LumiraDx?

Shares of LMDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LMDX) was last updated on 2/26/2024 by MarketBeat.com Staff